Login / Signup
Vedolizumab, an α4β7-Integrin Inhibitor, Exacerbates Ulcerative Colitis-Related Spondylitis.
Hirotaka Yamamoto
Yoshinori Taniguchi
Published in:
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases (2024)
Keyphrases
</>
ulcerative colitis
cell adhesion
cell migration
patients with inflammatory bowel disease